Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-20

FDA Approved: DECITABINE — Original Application (Eugia US LLC)

View source ↗

Summary

FDA approved Eugia US LLC's original application for a generic decitabine product indicated for myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Decitabine (Decitabine)

Snippet

ORIG AP for DECITABINE (DECITABINE)